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Background and Objectives
Health care related infections occur in nearly 12% of 
patients who admitted to pediatric intensive care units. 
Pneumonia is the second most common nosocomial 
infection that accounts for 22.7% of healthcare related 
infections. Ventilator-associated pneumonia (VAP), 
occurs in 9%-27% of intubated patients. The risk of 
VAP increases by about 1%-3% per day when using 
mechanical ventilation. Also, mortality rates for patients 
with VAP are reported about 33%-71% which is a high 
rate.1,2 In addition, some research has shown that 
mortality in children with VAP is significantly higher than 
in children without the disease.3 Also, hospital costs and 
length of stay in the neonatal intensive care unit (NICU) 
are significantly higher in patients with VAP compared to 
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Background and Objectives: Ventilator-associated pneumonia (VAP) is defined as inflammation of the lung 
parenchyma due to infectious agent activity 48 hours after the start of mechanical ventilation in patients who have 
tracheal intubation and did not have pneumonia at the time of intervention. Due to the lack of local information 
available and the high mortality rate, this study was designed to investigate the incidence of VAP and its related 
risk factors in patients admitted to neonatal intensive care unit (NICU) in Ardabil city hospital.
Methods: This descriptive cross- sectional study was performed on 100 neonates admitted to NICU of Bu-Ali 
hospital in Ardabil city in 2018. For each neonates, necessary information were collected by a checklist including 
incidence of VAP and the related risk factors. Collected data were analyzed by statistical methods in SPSS version 
19.
Findings: In this study, 100 neonates admitted to NICU of Ardabil city hospital, 61% of them were boys and 
the rest were girls. Out of all neonates, 48% had VAP. There was a significant relationship between duration of 
mechanical ventilation time and the incidence of VAP. Also, there were no significant relation between gender, 
gestational age (GA), receiving surfactant, steroids, vasoactive, enteral nutrition, re-intubation, blood transfusion 
and having nasogastric tube (NGT) with incidence of VAP. 
Conclusions: Results showed that the incidence of VAP in this study was increasing and we have to have 
strategic planning to reduce this rate in this area.
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Abstract
patients without the disease.4
Up to this time, many researchers have conducted 
studies on VAP risk factors in patients admitted to 
NICU but the results of these studies have been varied 
and inconsistent. For example, Elward et al in a study, 
identified genetic syndromes, re – intubation and 
outpatient care as risk factors related to VAP.5 Almuneef 
et al showed that arbitrary antibiotic therapy, continued 
enteral nutrition and bronchoscopy are the independent 
predictive risk factors for VAP.6 The epidemiology and 
prognosis of VAP for adults is well described but little 
information have about the disease specially for children , 
its risk factors and outcomes such as mortality, morbidity 
and costs.7 Because of the different anatomy and 
physiology of adults, identification of specific prevention 
methods for ventilator associated pneumonia in the 
pediatric population is essential.5
In addition, the information available is mainly related 
to studies in developed countries. The incidence of 
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ventilator associated pneumonia has been significantly 
reduced since 1990 due to improved clinical knowledge 
and the use of preventive methods and strategies but the 
incidence of the disease is still high.8
Because of these uncertainties, the lack of available 
information, the high mortality rate and the necessities 
mentioned, the aim of this study was to investigate the 
incidence of VAP and its related risk factors in patients 
admitted to NICU in Ardabil city hospital.
Methods
Study Design and Participants 
This descriptive cross-sectional study was performed on 
100 neonates under mechanical ventilation who admitted 
to NICU of Bu-Ali hospital in Ardabil city in 2018. 
Exclusion Criteria 
In cases of neonatal death occurring before pneumonia, 
occurrence of pneumonia at 48 hours after starting 
mechanical ventilation and non-using of mechanical 
ventilation neonates, neonates were excluded from the 
study . 
Data Collection Method 
Information for each neonates were collected by a 
checklist containing infant gender, gestational age (GA), 
length of mechanical ventilation time, occurrence of VAP 
and related risk factors such as receiving or non-receiving 
of steroids, surfactants, vasoactive, enteral nutrition, blood 
transfusion, NGT and re-intubation. 
Statistical Analysis 
Data were analyzed using descriptive analytical statistics 
in SPSS version 19. Chi-square and t test were used to 
examine the relationship between the variables. 
Ethical Approval 
The study was approved by the ethics committee of 
Ardabil University of medical science and registered by 
code IR.ARUMS.REC.1397.102. 
Results
In this study we investigated the incidence of VAP. Out of 
100 neonates, 48% had VAP. Of the total neonates, 61% 
were boys and 39% were girls . The incidence of VAP in 
girls with 52.1% was more than boys with 47.9% but the 
relation between gender and incidence of VAP was not 
significant. 
The average GA was about 33.1± 3.5 weeks in range 
24 to 40 weeks. In the VAP cases, the average GA was 
33 and in others was 33.4 and the difference was not 
significant. The average intubation time in neonates 
with VAP significantly higher than neonates without VAP 
(7.4±3.8 vs. 4.2±2, P=0.001). The difference between 
infants with incidence of VAP mechanical and intubation 
time was significant (Table 1).
Of all neonates, 76% received surfactants that 58% of 
whom had VAP. Also, 16.7% of those who did not receive 
surfactants, developed VAP. There was no significant 
relationship between surfactant receiving and incidence 
of VAP.
Of all neonates, 33% received steroids that 88% of 
them had VAP. Also, 38.4% of neonates who did not take 
steroids, developed VAP, too. There was no significant 
relationship between incidence of VAP and receiving 
steroids. 
Of all neonates, 56% received vasoactive drugs. Of 
them, 53.6% develop VAP. Also, 41% of those who did 
not receive the vasoactive developed VAP too and there 
was no significant relationship between vasoactive drug 
receipt and incidence of VAP.
Of all neonates, 15% had enteral nutrition of which 
73.3% had VAP. Also, 43.5% of those who did not eat 
Enteral had VAP. There was no significant relationship 
between receipt of enteral nutrition and incidence of VAP.
Of all neonates, 14% had NGT that 71.4% of them 
had VAP and also 44.2% of those who did not use NGT 
developed VAP and there was no significant relationship 
between them.
Of all neonates, 19% had re-intubation that all of them 
had VAP. Also, 35.8% of infants who have not been 
intubated again and have only been infected once, had 
Table 1. Relation Between Demographic Variables and Incidence of VAP
Some Related Variables 
Incidence of VAP
+ -
P Value
No. % No. %
Gender 
Girls 25 52.1 14 27
0.26
Boys 23 47.9 38 73
Gestational Age (wk) 33±3.2 33.4±3.8 0.57
Duration of mechanical ventilation (days) 7.4±3.8 4.2±2 0.001
Incidence of VAP and its Related Risk Factors
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VAP. There was no significant relationship between re-
intubation and the incidence of VAP.
 Of all neonates, 47% had blood transfusions that 61.7% 
of them VAP. Also, 35% of those who did not have blood 
transfusion, developed VAP. There was no significant 
relationship between blood transfusion and the incidence 
of VAP (Table 2). 
Discussion
In this study of all neonates, 48% had VAP. In the study of 
Albert et al only 6.5% of neonates had VAP that this high 
statistical difference may be due to the lack of appropriate 
conditions in our study for infants and the NICU problems 
in our study center. These findings suggest that the NICU 
system in our study requires more stringent preventive 
measures, further investigations on the type of risk 
factors study quality and efficiency of the used devices. 
Examination of the relationship between gender and 
ventilator associated VAP and our study results were 
similar to previous studies in this topic.9 Also due to the 
lack of studies on gender and incidence of VAP it is 
recommended to conduct more specific studies in this 
area with larger sample size as a case-control studies. 
The study on the incidence of VAP and GA showed no 
significant relationship between them. Although this is 
contrary to our expectation and it is not comparable to 
other studies due to lack of similar studies in this regard. 
Surveys showed that, 76% of patients received surfactants, 
33% received steroids and 56% received vasoactive 
drugs and there were no significant relationship between 
the use of these drugs with the incidence of VAP. Liu et al 
similar to our study showed that taking steroids is a strong 
risk factor for pneumonia.10 Kusahara et al suggested that 
the use of vasoactive drugs as an independent risk factor 
for ventilator associated pneumonia which is inconsistent 
with our study results.11 It is recommended to study a 
meta-analysis and systematic review about the upper risk 
factors. Although in our study no communication was found 
between gastric tube and incidence of VAP, in the study of 
Kusahara et al gastric nasal tube was identified as a risk 
factor for pneumonia and this conclusion need for more 
studies in future. Liu et al similarly to our study showed 
that re-intubation as a risk factor for ventilator- associated 
pneumonia.10 This suggests that re-intubation should be 
avoided as much as possible. It is recommended that 
more attention be given to extubating of neonates and that 
the clinical and paraclinical conditions of neonates should 
be carefully evaluated during extubating.11
Results showed that 15% of infants had enteral nutrition 
of which 73.3% had VAP. Also, 43% of those who did not 
eat enteral nutrition had VAP too. There was no significant 
relationship between receipt of enteral nutrition and 
incidence of VAP. In the study of Lee et al, a link was found 
between enteral nutrition and the incidence of pneumonia 
so that the beginning of enteral nutrition reduced the 
incidence of pneumonia but in the study of Albert et al this 
relation was not significant.12 In a study by Almuneef et al, 
continued enteral nutrition was identified as a risk factor 
for pneumonia.6 
Results are different based on the type of nutrition in 
Table 2. Relation between some related risk factors and Incidence of VAP
Risk Factors   
Incidence of VAP
P Value+ -
No. % No. %
Receiving surfactant 
Yes 44 58 32 42
0.35
No 4 16.7 20 83.3
Receiving steroids 
Yes 29 88 4 12
0.56
No 19 38.4 48 71.6
Receiving vasoactive 
Yes 30 53.6 26 46.4
0.21
No 18 41 26 59
Having NGT
Yes 10 71.4 4 28.6
0.08
No 38 44.2 48 55.8
Enteral nutrition
Yes 11 73.3 4 26.7
0.32
No                  37                  43.5 48 56.5
Re-intubation
Yes                  19                   100 0 0
0.51
No                  29                  35.8 52 64.2
Blood transfusion  
Yes                  29                  61.7 18 38.3
0.26
No                  19                   35.8 34 64.2
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neonates who hospitalized in the NICU. Although in 
our study no relation was found between NGT and the 
incidence of VAP, in the study by Kusahara et al, NGT 
defined as a risk factor for pneumonia.11 The study by Liu 
et al in contrast to our study strongly showed re-intubated 
as a factor for VAP.10 There were 47 cases of blood 
transfusions; 61.7% of them were infected. Also, 35% of 
those who did not have blood transfusions, developed 
the VAP. These findings showed a significant relationship 
between blood transfusion and VAP. 
The average intubation time in neonates with VAP 
significantly higher than neonates without VAP(7.4±3.8 
vs. 4.2±2, P=0.001). The difference between infants with 
incidence of VAP mechanical and intubation time was 
significant. Lee et al and Kusahara et al similar to our study 
showed a significant relationship between mechanical 
ventilation time and the incidence of VAP.11,12 Also a study 
by Vijayakanthi et al showed that prolonged mechanical 
ventilation time causes to ventilator related pneumonia.13 
All of these studies confirm that mechanical ventilation 
time is more likely to be a strong risk factor for pneumonia 
and it is recommended not to prolong infant intubation as 
long as possible. According to similar studies, steroids, re-
intubation, and length of stay in the NICU are factors that 
have been identified as important risk factors for ventilator 
associated pneumonia but in our studies these factors 
not confirmed to have role in the incidence of VAP. So, in 
hospitalized time of infants in NICU, these factors should 
be taken into account and infants with all three factors 
should be classified as high risk pneumonia patients . 
Conclusions
Given the association between ventilator associated 
pneumonia and steroid and surfactant receipt re intubation 
and intubation time it is recommended to reduce the above 
factors to reduce the morbidity and mortality caused by 
ventilator associated pneumonia. Since surfactants and 
intubation are necessary for preterm infants and steroid 
administration for extubation, it is recommended to be 
more careful in measuring the indications of the above 
measures. It is recommended to be more careful in 
measuring the indications of the above measures, also 
reduce the birth rate of premature infants and give steroid 
to the prenatal mother to accelerate lung maturation to 
minimize infant intubation and minimize complications, 
including ventilator associated pneumonia. Studies on 
the subsequent complications of ventilator- associated 
pneumonia, the type of native tag causing neonatal 
pneumonia, the use of steroids and VAP, and the re-
intubation of VAP could be used as a more comprehensive 
view of the importance of this issue and of the native 
treatment strategy for community health decision makers 
and hospital system managers.
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